Literature DB >> 27312397

The liver throws the skeleton a bone (resorption factor).

Chuhan Chung1,2, Karl L Insogna1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27312397      PMCID： PMC4992574          DOI： 10.1002/hep.28688

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.

Authors:  Jody Dushay; Patricia C Chui; Gosala S Gopalakrishnan; Marta Varela-Rey; Meghan Crawley; Ffolliott M Fisher; Michael K Badman; Maria L Martinez-Chantar; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

2.  Elevated IGFBP-1 cause high bone turnover in growth-restricted monochorionic twins with discordant birth weight.

Authors:  Rekha Bajoria; Suren R Sooranna; Stuart Ward; Ratna Chatterjee
Journal:  Bone       Date:  2005-12-07       Impact factor: 4.398

3.  Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.

Authors:  Wei Wei; Paul A Dutchak; Xunde Wang; Xunshan Ding; Xueqian Wang; Angie L Bookout; Regina Goetz; Moosa Mohammadi; Robert D Gerard; Paul C Dechow; David J Mangelsdorf; Steven A Kliewer; Yihong Wan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

4.  Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.

Authors:  Mathieu Ferron; Jianwen Wei; Tatsuya Yoshizawa; Andrea Del Fattore; Ronald A DePinho; Anna Teti; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

5.  High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.

Authors:  E Shmueli; J P Miell; M Stewart; K G Alberti; C O Record
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

6.  Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials.

Authors:  Ann V Schwartz; Anne L Schafer; Andrew Grey; Eric Vittinghoff; Lisa Palermo; Li-Yung L Lui; Robert B Wallace; Steven R Cummings; Dennis M Black; Douglas C Bauer; Ian R Reid
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

7.  A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption.

Authors:  Xunde Wang; Wei Wei; Jing Y Krzeszinski; Yubao Wang; Yihong Wan
Journal:  Cell Metab       Date:  2015-10-08       Impact factor: 27.287

8.  Risk-adjusted mortality rates of elderly veterans with hip fractures.

Authors:  Elizabeth Bass; Dustin D French; Douglas D Bradham; Laurence Z Rubenstein
Journal:  Ann Epidemiol       Date:  2007-04-08       Impact factor: 3.797

9.  Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study.

Authors:  Stephen R Pye; Bader Almusalam; Steven Boonen; Dirk Vanderschueren; Herman Borghs; Evelien Gielen; Judith E Adams; Kate A Ward; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Fernand Labrie; Michael E J Lean; Neil Pendleton; Margus Punab; Alan J Silman; Frederick C W Wu; Terence W O'Neill
Journal:  Calcif Tissue Int       Date:  2011-04-19       Impact factor: 4.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.